BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 8793703)

  • 1. Difference between office and ambulatory blood pressure and response to antihypertensive treatment.
    Parati G; Omboni S; Mancia G
    J Hypertens; 1996 Jun; 14(6):791-7. PubMed ID: 8793703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive efficacy of lercanidipine at 2.5, 5 and 10 mg in mild to moderate essential hypertensives assessed by clinic and ambulatory blood pressure measurements. Multicenter Study Investigators.
    Omboni S; Zanchetti A
    J Hypertens; 1998 Dec; 16(12 Pt 1):1831-8. PubMed ID: 9869018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between changes in left ventricular mass and in clinic and ambulatory blood pressure in response to antihypertensive therapy.
    Fagard RH; Staessen JA; Thijs L
    J Hypertens; 1997 Dec; 15(12 Pt 1):1493-502. PubMed ID: 9431857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitations of the difference between clinic and daytime blood pressure as a surrogate measure of the 'white-coat' effect. Syst-Eur investigators.
    Parati G; Omboni S; Staessen J; Thijs L; Fagard R; Ulian L; Mancia G
    J Hypertens; 1998 Jan; 16(1):23-9. PubMed ID: 9533413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of the "white-coat effect" by antihypertensive treatment and regression of target organ damage.
    Parati G; Ulian L; Sampieri L; Palatini P; Villani A; Vanasia A; Mancia G
    Hypertension; 2000 Feb; 35(2):614-20. PubMed ID: 10679506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the lercanidipine-enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database.
    Mancia G; Omboni S; Chazova I; Coca A; Girerd X; Haller H; Parati G; Pauletto P; Pupek-Musialik D; Svyshchenko Y;
    J Hypertens; 2016 Jan; 34(1):139-48. PubMed ID: 26630216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty-four hour ambulatory blood pressure in the Hypertension Optimal Treatment (HOT) study.
    Mancia G; Omboni S; Parati G; Clement DL; Haley WE; Rahman SN; Hoogma RP
    J Hypertens; 2001 Oct; 19(10):1755-63. PubMed ID: 11593094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between ambulatory blood pressure and follow-up clinic blood pressure in elderly patients with systolic hypertension.
    Fagard RH; Staessen JA; Thijs L; Bulpitt CJ; Clement D; de Leeuw PW; Jääskivi M; Mancia G; O'Brien E; Palatini P; Tuomilehto J; Webster J;
    J Hypertens; 2004 Jan; 22(1):81-7. PubMed ID: 15106798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure response to antihypertensive therapy: ambulatory versus office blood pressure readings.
    Rion F; Waeber B; Graf HJ; Jaussi A; Porchet M; Brunner HR
    J Hypertens; 1985 Apr; 3(2):139-43. PubMed ID: 4020121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White coat effect in treated and untreated patients with high office blood pressure. Relationship with pulse wave velocity and left ventricular mass index.
    Silveira A; Mesquita A; Maldonado J; Silva JA; Polónia J
    Rev Port Cardiol; 2002 May; 21(5):517-30. PubMed ID: 12174516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of fosinopril/hydrochlorothiazide combinations on ambulatory blood pressure profiles in hypertension. Fosinopril/Hydrochlorothiazide Investigators.
    Guthrie R; Reggi DR; Plesher MM; Saini RK; Battikha JP
    Am J Hypertens; 1996 Apr; 9(4 Pt 1):306-11. PubMed ID: 8722432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of clinical and ambulatory measurements of blood pressure with benazepril alone or combined with hydrochlorothiazide in hypertension].
    Le Feuvre C; Francillon A; Renucci JF; Cocco-Guyomarch L; Muller M; Peuplier P; Poggi L
    Therapie; 1996; 51(1):27-34. PubMed ID: 8762217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension.
    Mallion JM; Omboni S; Barton J; Van Mieghem W; Narkiewicz K; Panzer PK; Puig JG; Stefanadis C; Zweiker R;
    Blood Press Suppl; 2011 Apr; 1():3-11. PubMed ID: 21091270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of the antihypertensive efficacy of once-daily sustained-release isradipine and lacidipine using 24-hour ambulatory blood-pressure monitoring.
    Galderisi M; Petrocelli A; Garofalo M; Celentano A; Alfieri A; de Divitiis O
    J Int Med Res; 1995; 23(4):234-43. PubMed ID: 7589766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Reverse white-coat hypertension' in older hypertensives.
    Wing LM; Brown MA; Beilin LJ; Ryan P; Reid CM;
    J Hypertens; 2002 Apr; 20(4):639-44. PubMed ID: 11910298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambulatory blood pressure monitoring and clinical characteristics of the true and white-coat resistant hypertension.
    Veglio F; Rabbia F; Riva P; Martini G; Genova GC; Milan A; Paglieri C; Carra R; Chiandussi L
    Clin Exp Hypertens; 2001 Apr; 23(3):203-11. PubMed ID: 11339687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.